INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 428.14 million | 8.2% | Asia Pacific |
| By Type | By Application | By Region |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Nicotinamide Mononucleotide (NMN) Market Overview
The global nicotinamide mononucleotide (NMN) market size is projected to reach USD 428.14 million by 2029, from USD 210.64 million in 2020, at a CAGR of 8.2% during 2020-2029.
Nicotinamide mononucleotide (NMN) is a naturally occurring molecule within the body, derived from niacin, also known as vitamin B3. NMN plays a pivotal role in numerous biological processes, particularly in energy metabolism and DNA repair, as it participates in the production of nicotinamide adenine dinucleotide (NAD+), a vital coenzyme for cellular functions.
Studies indicate that supplementing with NMN may offer potential health advantages, such as improved mitochondrial function, metabolism enhancement, and increased lifespan in animal models. Moreover, NMN has garnered attention for its potential in addressing age-related decline and certain age-associated conditions.
With the global population aging, there’s an increasing demand for products and supplements that support healthy aging. Consumers seeking anti-aging solutions may find NMN appealing due to its purported ability to activate sirtuins, a group of proteins associated with longevity and cellular health. This growing consumer emphasis on health and well-being drives the search for solutions to combat age-related ailments, aligning with the perceived benefits of NMN, which include enhanced metabolism, energy production, and DNA repair.
Ongoing studies and clinical trials continue to uncover NMN’s potential health benefits and mechanisms of action. Market demand is fueled by increasing consumer confidence in NMN as scientific evidence supporting its safety and efficacy accumulates.
NMN is commonly available as a dietary supplement, and the global dietary supplement market is experiencing rapid growth due to rising consumer awareness of preventive healthcare and the increasing prevalence of chronic diseases. Incorporating NMN into product formulations contributes to the expansion of the dietary supplement industry.
Regulatory bodies in various countries are establishing supportive regulatory frameworks for the marketing and sale of dietary supplements containing NMN. A clear regulatory environment fosters market growth by instilling confidence in the quality and safety of NMN products among manufacturers and consumers alike.
Nicotinamide Mononucleotide (NMN) Market Segment Analysis
Nicotinamide Mononucleotide (NMN) market is segmented on the basis of type as content below 98% and content above 98%; on the base of application as health care products and cosmetics.
Nicotinamide Mononucleotide (NMN) Key Market Players
The key market players dominating the NMN market are GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, Bontac, Shandong Sihuan Pharmaceutical, EffePharm, Zhejiang Jiahua Pharmchemicals among others.
- Herbalmax focus on developing, manufacturing and licensing scientifically sound and clinically recognized natural dietary supplements.
- GeneHarbor (Hong Kong) Biotechnologies Limited is a biotechnology firm that manufactures a variety of enzymes for a variety of purposes.
- Shinkowa Pharmaceutical Co., Ltd. is a pharmaceutical company that has developed and sells dietary supplements and cosmetics.
Who Should Buy? Or Key Stakeholders
- Healthcare Industry
- Hospitals
- Pharmaceutical Industries
- Cosmetic Industries
- Chemical Industry
- Investors
- Manufacturing companies
- End user companies
Key Takeaways:
- The global nicotinamide mononucleotide (NMN) market grow at a CAGR of 8.2%
- Asia Pacific region is projected to show the largest market for NMN market.
- Based on type, content Above 98% is expected to dominate the market in this segment
- Based on application, Health Care Products is expected to dominate the market in this segment
- The Nicotinamide Mononucleotide (NMN) Market is witnessing growth due to increasing demand for anti-aging supplements and potential health benefits.
Nicotinamide Mononucleotide (NMN) Market Regional Analysis
The market for NMN region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
Asia Pacific region is projected to show the largest market for NMN market. With the steady increase in the disposable income of Chinese residents and the dual impact of consumption upgrades and increased consumer awareness brought about by new digital media marketing, consumers’ acceptance of NMN has gradually increased, and the demand for the NMN industry has accelerated. At present, domestic companies in this region have registered companies abroad or acquired nutritional products companies to develop NMN formulas and brands. After production is completed abroad, they can be sold to China through cross-border e-commerce channels.
Key Market Segments: NMN Market
NMN Market By Type, 2020-2029, ( USD Million) (Kilotons)
- Content Below 98%
- Content Above 98%
NMN Market By Application, 2020-2029, (USD Million) (Kilotons)
- Health Care Products
- Cosmetics
NMN Market by Region, 2020-2029, (USD Million) (Kilotons)
- North America
- Europe
- Asia Pacific
- South America
- Middle East and Africa
Important countries all regions are covered.
Key Question Answered
- What are the growth opportunities related to the adoption of NMN across major regions in the future?
- What are the new trends and advancements in the NMN market?
- Which product categories are expected to have highest growth rate in the NMN market?
- Which are the key factors driving the NMN market?
- What will the market growth rate, growth momentum or acceleration the market carries during the forecast period?
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global Nicotinamide Mononucleotide (NMN) Market Outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 On Global Nicotinamide Mononucleotide (NMN) Market
- Global Nicotinamide Mononucleotide (NMN) Market Outlook
- Global Nicotinamide Mononucleotide (NMN) Market by Type, (USD Million) (Kilotons)
- Content Below 98%
- Content Above 98%
- Global Nicotinamide Mononucleotide (NMN) Market by Application, (USD Million) (Kilotons)
- Health Care Products
- Cosmetics
- Global Nicotinamide Mononucleotide (NMN) Market by Region, (USD Million) (Kilotons)
- Introduction
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- South-East Asia
- Rest of Asia-Pacific
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Rest of Europe
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
- Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)
-
- GeneHarbor
- Herbalmax
- Genex Formulas
- Shinkowa Pharmaceutical
- Maac10 Formulas
- Bontac
- Shandong Sihuan Pharmaceutical
- EffePharm
- Zhejiang Jiahua Pharmchemicals
- Others
*The Company List Is Indicative
Â
Â
LIST OF TABLESÂ
TABLE 1Â Â Â Â Â Â Â Â Â GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY REGION (USD MILLIONS) 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY REGION (KILOTONS) 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â US NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â US NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â US NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 10Â Â Â Â Â Â Â US NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 11Â Â Â Â Â Â Â CANADA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 12Â Â Â Â Â Â Â CANADA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 13Â Â Â Â Â Â Â CANADA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 14Â Â Â Â Â Â Â CANADA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 15Â Â Â Â Â Â Â MEXICO NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 16Â Â Â Â Â Â Â MEXICO NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 17Â Â Â Â Â Â Â MEXICO NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 18Â Â Â Â Â Â Â MEXICO NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 19Â Â Â Â Â Â Â BRAZIL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 20Â Â Â Â Â Â Â BRAZIL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 21Â Â Â Â Â Â Â BRAZIL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 22Â Â Â Â Â Â Â BRAZIL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 23Â Â Â Â Â Â Â ARGENTINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 24Â Â Â Â Â Â Â ARGENTINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 25Â Â Â Â Â Â Â ARGENTINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 26Â Â Â Â Â Â Â ARGENTINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 27Â Â Â Â Â Â Â COLOMBIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 28Â Â Â Â Â Â Â COLOMBIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 29Â Â Â Â Â Â Â COLOMBIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 30Â Â Â Â Â Â Â COLOMBIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 31Â Â Â Â Â Â Â REST OF SOUTH AMERICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 32Â Â Â Â Â Â Â REST OF SOUTH AMERICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 33Â Â Â Â Â Â Â REST OF SOUTH AMERICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 34Â Â Â Â Â Â Â REST OF SOUTH AMERICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 35Â Â Â Â Â Â Â INDIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 36Â Â Â Â Â Â Â INDIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 37Â Â Â Â Â Â Â INDIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 38Â Â Â Â Â Â Â INDIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 39Â Â Â Â Â Â Â CHINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 40Â Â Â Â Â Â Â CHINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 41Â Â Â Â Â Â Â CHINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 42Â Â Â Â Â Â Â CHINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 43Â Â Â Â Â Â Â JAPAN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 44Â Â Â Â Â Â Â JAPAN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 45Â Â Â Â Â Â Â JAPAN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 46Â Â Â Â Â Â Â JAPAN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 47Â Â Â Â Â Â Â SOUTH KOREA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 48Â Â Â Â Â Â Â SOUTH KOREA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 49Â Â Â Â Â Â Â SOUTH KOREA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 50Â Â Â Â Â Â Â SOUTH KOREA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 51Â Â Â Â Â Â Â AUSTRALIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 52Â Â Â Â Â Â Â AUSTRALIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 53Â Â Â Â Â Â Â AUSTRALIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 54Â Â Â Â Â Â Â AUSTRALIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 55Â Â Â Â Â Â Â SOUTH-EAST ASIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 56Â Â Â Â Â Â Â SOUTH-EAST ASIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 57Â Â Â Â Â Â Â SOUTH-EAST ASIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 58Â Â Â Â Â Â Â SOUTH-EAST ASIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 59Â Â Â Â Â Â Â REST OF ASIA PACIFIC NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 60Â Â Â Â Â Â Â REST OF ASIA PACIFIC NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 61Â Â Â Â Â Â Â REST OF ASIA PACIFIC NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 62Â Â Â Â Â Â Â REST OF ASIA PACIFIC NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 63Â Â Â Â Â Â Â GERMANY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 64Â Â Â Â Â Â Â GERMANY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 65Â Â Â Â Â Â Â GERMANY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 66Â Â Â Â Â Â Â GERMANY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 67Â Â Â Â Â Â Â UK NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 68Â Â Â Â Â Â Â UK NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 69Â Â Â Â Â Â Â UK NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 70Â Â Â Â Â Â Â UK NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 71Â Â Â Â Â Â Â FRANCE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 72Â Â Â Â Â Â Â FRANCE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 73Â Â Â Â Â Â Â FRANCE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 74Â Â Â Â Â Â Â FRANCE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 75Â Â Â Â Â Â Â ITALY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 76Â Â Â Â Â Â Â ITALY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 77Â Â Â Â Â Â Â ITALY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 78Â Â Â Â Â Â Â ITALY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 79Â Â Â Â Â Â Â SPAIN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 80Â Â Â Â Â Â Â SPAIN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 81Â Â Â Â Â Â Â SPAIN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 82Â Â Â Â Â Â Â SPAIN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 83Â Â Â Â Â Â Â RUSSIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 84Â Â Â Â Â Â Â RUSSIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 85Â Â Â Â Â Â Â RUSSIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 86Â Â Â Â Â Â Â RUSSIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 87Â Â Â Â Â Â Â REST OF EUROPE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 88Â Â Â Â Â Â Â REST OF EUROPE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 89Â Â Â Â Â Â Â REST OF EUROPE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 90Â Â Â Â Â Â Â REST OF EUROPE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 91Â Â Â Â Â Â Â UAE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 92Â Â Â Â Â Â Â UAE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 93Â Â Â Â Â Â Â UAE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 94Â Â Â Â Â Â Â UAE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 95Â Â Â Â Â Â Â SAUDI ARABIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 96Â Â Â Â Â Â Â SAUDI ARABIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 97Â Â Â Â Â Â Â SAUDI ARABIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 98Â Â Â Â Â Â Â SAUDI ARABIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 99Â Â Â Â Â Â Â SOUTH AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 100Â Â Â Â Â SOUTH AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 101Â Â Â Â Â SOUTH AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 102Â Â Â Â Â SOUTH AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
TABLE 103Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029
TABLE 104Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029
TABLE 105Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029
TABLE 106Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE, USD MILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION, USD MILLION, 2020-2029
FIGURE 10Â Â Â GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 11   PORTER’S FIVE FORCES MODEL
FIGURE 12Â Â Â GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE 2020
FIGURE 13Â Â Â GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION 2020
FIGURE 14Â Â Â NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY REGION 2020
FIGURE 15Â Â Â MARKET SHARE ANALYSIS
FIGURE 16Â Â Â GENEHARBOR: COMPANY SNAPSHOT
FIGURE 17Â Â Â HERBALMAX: COMPANY SNAPSHOT
FIGURE 18Â Â Â GENEX FORMULAS: COMPANY SNAPSHOT
FIGURE 19Â Â Â SHINKOWA PHARMACEUTICAL: COMPANY SNAPSHOT
FIGURE 20Â Â Â MAAC10 FORMULAS: COMPANY SNAPSHOT
FIGURE 21Â Â Â BONTAC: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â SHANDONG SIHUAN PHARMACEUTICAL: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â EFFEPHARM: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â ZHEJIANG JIAHUA PHARMCHEMICALS: COMPANY SNAPSHOT
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.